Interpreting Cardiovascular Endpoints in Trials of Antihyperglycemic Drugs.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 3, p. 203, doi. 10.1007/s40256-017-0215-6
- By:
- Publication type:
- Article
Works matching IS 11753277 AND DT 2017 AND VI 17 AND IP 3
Results: 9
1
2
Results of an International Postmarketing Surveillance Study of pl-VEGF165 Safety and Efficacy in 210 Patients with Peripheral Arterial Disease.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 3, p. 235, doi. 10.1007/s40256-016-0210-3
- By:
- Publication type:
- Article
3
Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 3, p. 183, doi. 10.1007/s40256-016-0211-2
- By:
- Publication type:
- Article
4
Rates of Nonsteroidal Anti-Inflammatory Drug Use in Patients with Established Cardiovascular Disease: A Retrospective, Cross-Sectional Study from NHANES 2009-2010.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 3, p. 243, doi. 10.1007/s40256-016-0212-1
- By:
- Publication type:
- Article
5
Erratum to: Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 3, p. 233, doi. 10.1007/s40256-017-0228-1
- By:
- Publication type:
- Article
6
Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 3, p. 217, doi. 10.1007/s40256-017-0216-5
- By:
- Publication type:
- Article
7
No Effect of Omega-3 Carboxylic Acids on Pharmacokinetics/Pharmacodynamics of Warfarin or on Platelet Function When Co-administered with Acetylsalicylic Acid: Results of Two Phase I Studies in Healthy Volunteers.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 3, p. 251, doi. 10.1007/s40256-017-0217-4
- By:
- Publication type:
- Article
8
66th Annual Scientific Sessions of the American College of Cardiology: 17-19 March 2017; Washington, DC, USA.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 3, p. 261, doi. 10.1007/s40256-017-0234-3
- By:
- Publication type:
- Article
9
Defining the Place of Ezetimibe/Atorvastatin in the Management of Hyperlipidemia.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 3, p. 169, doi. 10.1007/s40256-016-0205-0
- By:
- Publication type:
- Article